Version history
1 version on record. Newest first; the live version sits at the top with a live indicator.
- Live4/30/2026, 2:41:24 PM
sha256:7d63aContent snapshot
{ "nct_id": "NCT03761849", "phase": "phase_3", "status": "terminated", "domain": "huntingtons", "indication": "Manifest Huntington's Disease", "intervention": "Tominersen (antisense oligonucleotide targeting HTT)", "sponsor": "Roche", "n_enrolled": 791, "primary_endpoint": "cUHDRS at 101 weeks", "summary": "Halted March 2021 — exploratory analyses suggested potential harm from non-allele-specific HTT lowering. Reframed the field around earlier intervention + allele-selective targeting.", "metadata": {} }